Lumos Diagnostics Holdings Limited (LDXHF)

OTCMKTS · Delayed Price · Currency is USD

0.0600

-0.0030 (-4.76%)

At close: Jul 17, 2026

69.49% (1Y)

Market Cap	52.76M +51.7%
Revenue (ttm)	12.21M -16.7%
Net Income	-9.26M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,004
Open	0.0600
Previous Close	0.0630
Day's Range	0.0600 - 0.0600
52-Week Range	0.0460 - 0.2400
Beta	0.55
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About LDXHF

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platfor... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2018

Country Australia

Stock Exchange OTCMKTS

Ticker Symbol LDXHF

Financial Performance

In fiscal year 2025, LDXHF's revenue was $12.40 million, an increase of 11.40% compared to the previous year's $11.13 million. Losses were -$7.18 million, -16.40% less than in 2024.

Financial Statements